Apoptotic Cell Death by Pectenotoxin-2 in p53-Deficient Human Hepatocellular Carcinoma Cells
![]() |
Shin, Dong-Yeok
(Department of Biochemistry, Dongeui University College of Oriental Medicine)
Kim, Gi-Young (Faculty of Applied Marine Science, Cheju National Univeristy) Choi, Byung-Tae (Department of Anatomy, School of Oriental Medicine, Pusan National University) Kang, Ho-Sung (Department of Molecular Biology, Pusan National University) Jung, Jee-H. (Department of Pharmacy, Pusan National University) Choi, Yung-Hyun (Department of Biochemistry, Dongeui University College of Oriental Medicine) |
1 | Jung, J. H., C. J. Sim and C. O. Lee. 1995. Cytotoxic compounds from a two-sponge association. J. Nat. Prod. 58, 1722-1726. DOI |
2 | Karin, M. 1995. The regulation of AP-1 activity by mitogenactivated protein kinases. J. Biol. Chem. 270, 16483-16486. DOI |
3 | Moll, U. M., S. Wolff, D. Speidel and W. Deppert. 2005. Transcription-independent pro-apoptotic functions of p53. Curr. Opin. Cell Biol. 17, 631-636. DOI ScienceOn |
4 | Murakami, Y., K. Hayashi, S. Hirohashi and T. Sekiya. 1991. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res. 51, 5520-5525. |
5 | Nagata, S., H. Nagase, K. Kawane, N. Mukae and H. Fukuyama. 2003. Degradation of chromosomal DNA during apoptosis. Cell Death Differ. 10, 108-116. DOI ScienceOn |
6 | Osford, S. M., C. L. Dallman, P. W. Johnson, A. Ganesan and G. Packham. 2004. Current strategies to target the anti- apoptotic Bcl-2 protein in cancer cells. Curr. Med. Chem. 11, 1031-1039. DOI ScienceOn |
7 | Rosse, T., R. Olivier, L. Monney, M. Rager, S. Conus, I. Fellay, B. Jansen and C. Borner. 1998. Bcl-2 prolongs cell survival after Bax induced release of cytochrome c. Nature 391, 496-499. DOI ScienceOn |
8 | Schulze-Osthoff, K., D. Ferrari, M. Los, S. Wesselborg and M. E. Peter. 1998. Apoptosis signaling by death receptors. Eur. J. Biochem. 254, 439-459. DOI ScienceOn |
9 | Sheikh, M. S. and Y. Huang. 2004. Death receptors as targets of cancer therapeutics. Curr. Cancer Drug Targets 4, 97-104. DOI ScienceOn |
10 | Zinkel, S., A. Gross and E. Yang. 2006. Bcl-2 family in DNA damage and cell cycle control. Cell Death Differ. 13, 1351-1359. DOI ScienceOn |
11 |
Baldwin, A. 1996. The NF- |
12 | Chae, H. D., T. S. Choi, B. M. Kim, J. H. Jung, Y. J. Bang and D. Y. Shin. 2005. Oocyte-based screening of cytokinesis inhibitors and identification of pectenotoxin-2 that induces Bim/Bax-mediated apoptosis in p53-deficient tumors. Oncogene 24, 4813-4819. DOI ScienceOn |
13 | Coutts, A. S and L. A. Thangue. 2006. The p53 response during DNA damage: impact of transcriptional cofactors. Biochem. Soc. Symp. 73, 181-189. |
14 | Datta, S. R., A. Brunet and M. E. Greenberg. 1999. Cellular survival: a play in three Akts. Genes Dev. 13, 2905-2927. DOI ScienceOn |
15 | Degen, W. G., G. J. Pruijn, J. M Raats and W. J. van Venrooij. 2000. Caspase dependent cleavage of nucleic acids. Cell Death Differ. 7, 616-627. DOI ScienceOn |
16 | Derjard, B., J. Raingeaud, T. Barrett, J. Han, R. J. Ulevitch and R. J. Davis. 1995. Independent human MAP-kinase signal transduction pathway defined by MEK and MKK isoforms. Science 267, 682-685. DOI ScienceOn |
17 | el-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, T. M. Trent, D. Lin, W. E. Mercer, K. E Kinzler and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825. DOI ScienceOn |
18 | Giono, L. E and J. J. Manfredi. 2006. The p53 tumor suppressor participates in multiple cell cycle checkpoints. J. Cell Physiol. 209, 13-20. DOI ScienceOn |
19 | Halaby, M. J. and D. Q. Yang. 2007. p53 translational control: a new facet of p53 regulation and its implication for tumorigenesis and cancer therapeutics. Gene 395, 1-7. DOI ScienceOn |
20 | Han, J., J. D. Lee, L. Bibbs and R. J. Ulevitch. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammaliam cells. Science 265, 808-811. DOI |
21 |
Baeuerie, P. A. and T. Henkel. 1994. Function and activation of NF- |
![]() |